CCR2 and neoplasm: Next, we evaluated 4H11-CCR2b and 4H11-CCR5 cytotoxicity against OVCAR3 and patient derived tumor organoid ET2 over 120 h and found sustained cytotoxicity over time in both the cell line and patient derived organoid (Figure 3D).